Belite Bio BLTE
NASDAQ BLTE
$150.27 -2.91 (-1.90%)
At close: Oct 22, 2026 · 4:00 PM EDT

Belite Bio (BLTE) Net Shares Issued and Repurchased (2024 - 2025)

Updated

Analysis

Belite Bio (BLTE) Net Shares Issued and Repurchased (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -966.00 Mn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -9.00 Mn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 6.00 Mn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Belite Bio 4.96 Bn 4.96 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 110.48 Mn
Dec 31, 2024 31.52 Mn
API Access

Belite Bio Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=BLTE&period=max&api_key=YOUR_API_KEY